Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

dorsaVi (ASX:DVL) Shares Fall Over 4% After FY26 Loss Widens to $8.5 Million

dorsaVi reported total revenue and other income of approximately $1.59 million for FY26, compared with $1.51 million in the previous financial year, an increase of 5.8%. Within this, sales revenue was $1.00 million, down from $1.13 million in the prior period, which the company …

Sonal Goyal | 03 September 2026

Micro-X (ASX:MX1) Shares Drop Nearly 8% - $1.6 Million ARPA-H Milestone Payment in Focus

During the quarter, Micro-X commenced its Head CT human imaging pilot study at the Royal Melbourne Hospital, the first phase of its clinical validation study involving fine-tuning of algorithms using data from the initial human head images captured with the device. The second phase …

Sonal Goyal | 03 September 2026

INOVIQ (ASX:IIQ) Gains 9%—Can the EXO-OC Test Rebuild Investor Confidence?

INOVIQ (ASX:IIQ) is gaining traction on 3 September 2026, with the stock trading at AUD 0.19, up 8.57% during the session. It reached an intraday high of AUD 0.190 and a low of AUD 0.180, with 98,988 shares changing hands. The company is valued …

Aditi Sarkar | 03 September 2026

Paradigm Biopharmaceuticals (ASX:PAR) Advances 9%—Will Phase 3 Progress Shift Sentiment?

Paradigm Biopharmaceuticals (ASX:PAR) is gaining traction on 3 September 2026, with the stock trading at AUD 0.24, up 9.09% during the session. It reached an intraday high of AUD 0.245 and a low of AUD 0.210, with 2,116,706 shares changing hands. The company is …

Aditi Sarkar | 03 September 2026

Actinogen Medical (ASX:ACW) Adds 9%—Are XanaMIA Results the Next Major Test?

Actinogen Medical (ASX:ACW) is gaining traction on 3 September 2026, with the stock trading at AUD 0.047, up 9.30% during the session. It reached an intraday high of AUD 0.047 and a low of AUD 0.044, with 5,876,444 shares changing hands. The company is …

Aditi Sarkar | 03 September 2026

PainChek (ASX:PCK) Rebounds 9%—Can US Expansion Change the Direction of the Stock?

PainChek (ASX:PCK) is gaining traction on 3 September 2026, with the stock trading at AUD 0.105, up 9.38% during the session. It reached an intraday high of AUD 0.105 and a low of AUD 0.100, with 93,463 shares changing hands. The company is valued …

Aditi Sarkar | 03 September 2026

Cleo Diagnostics (ASX:COV) Rises 10%—How Close Is Its Ovarian Cancer Test to Market?

Cleo Diagnostics (ASX:COV) is gaining traction on 3 September 2026, with the stock trading at AUD 0.385, up 10.00% during the session. It reached an intraday high of AUD 0.395 and a low of AUD 0.385, with 24,324 shares changing hands. The company is …

Aditi Sarkar | 03 September 2026

CleanSpace Holdings (ASX:CSX) Gains 10%—Can New Respirator Orders Revive Growth?

CleanSpace Holdings (ASX:CSX) is gaining traction on 3 September 2026, with the stock trading at AUD 0.475, up 10.47% during the session. It reached an intraday high of AUD 0.475 and a low of AUD 0.430, with 35,281 shares changing hands. The company is …

Aditi Sarkar | 03 September 2026

Cambium Bio (ASX:CMB) Climbs 15%—What Could Reset the Elate Ocular Story?

Cambium Bio (ASX:CMB) is gaining traction on 3 September 2026, with the stock trading at AUD 0.45, up 15.39% during the session. It reached an intraday high of AUD 0.450 and a low of AUD 0.430, with 1,732 shares changing hands. The company is …

Aditi Sarkar | 03 September 2026

Memphasys (ASX:MEM) Jumps 20% as Felix Opens the Door to Turkish IVF Sales

Memphasys (ASX:MEM) is gaining traction on 3 September 2026, with the stock trading at AUD 0.006, up 20.00% during the session. It reached an intraday high of AUD 0.006 and a low of AUD 0.006, with 1,000,000 shares changing hands. The company is valued …

Aditi Sarkar | 03 September 2026
Support

Hi! How can we help you today?

Loading…